Akari Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AKTX and other ETFs, options, and stocks.

About AKTX

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. 

CEO
Rachelle Jacques
CEORachelle Jacques
Employees
15
Employees15
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2004
Founded2004
Employees
15
Employees15

AKTX Key Statistics

Market cap
10.12M
Market cap10.12M
Price-Earnings ratio
-0.29
Price-Earnings ratio-0.29
Dividend yield
Dividend yield
Average volume
8.84K
Average volume8.84K
High today
$2.00
High today$2.00
Low today
$1.97
Low today$1.97
Open price
$2.00
Open price$2.00
Volume
1.86K
Volume1.86K
52 Week high
$5.72
52 Week high$5.72
52 Week low
$1.95
52 Week low$1.95
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.